John E. Bailey, Jr

2021

In 2021, John E. Bailey, Jr earned a total compensation of $8.7M as Chief Executive Officer and President at G1 Therapeutics, a 1,048% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$294,000
Option Awards$3,830,194
Salary$735,000
Stock Awards$3,837,861
Other$8,700
Total$8,705,755

Bailey received $3.8M in stock awards, accounting for 44% of the total pay in 2021.

Bailey also received $294K in non-equity incentive plan, $3.8M in option awards, $735K in salary and $8.7K in other compensation.

Rankings

In 2021, John E. Bailey, Jr's compensation ranked 1,279th out of 12,415 executives tracked by ExecPay. In other words, Bailey earned more than 89.7% of executives.

ClassificationRankingPercentile
All
1,279
out of 12,415
90th
Division
Manufacturing
454
out of 5,505
92nd
Major group
Chemicals And Allied Products
166
out of 2,375
93rd
Industry group
Drugs
138
out of 2,096
93rd
Industry
Pharmaceutical Preparations
91
out of 1,546
94th
Source: SEC filing on April 26, 2023.

Bailey's colleagues

We found two more compensation records of executives who worked with John E. Bailey, Jr at G1 Therapeutics in 2021.

2021

Jennifer Moses

G1 Therapeutics

Chief Financial Officer

2021

Mark Avagliano

G1 Therapeutics

Chief Business Officer

News

You may also like